Globus Medical Receives CE Mark For Its Excelsius3D Imaging System For Commercial Sale In EU, U.K.
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, today announced that the Excelsius3D™ intelligent 3-in-1 imaging system is now CE marked for commercial sale in the European Union and the
Globus Medical got official approval to sell a special 3-in-1 imaging machine in Europe and the U.K. This is good because it opens a new market for the company, though the real impact depends on how many hospitals actually buy it.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.